You signed the LOI.Now fund the acquisition.
A live working session for operators acquiring a healthcare or operating business under a signed LOI. Approved for part of the capital stack, and short the rest. Built for operators, not CFOs.
Closed to anyone without a signed LOI.
“We are not a lender and not a fund. We structure the capital file, and connect the right capital provider to the right deal.”
You did everything right. The money still stopped short.
You have a transaction everyone agrees is solid. Then it dies on one exposure, the single risk the capital provider simply refuses to carry:
Then the financing he had assumed would carry the purchase stopped short. His lender approved him, but only for part of it. He was approved for one number, and the acquisition, with the roll-up he had planned behind it, needed a far bigger one. The equity he was suddenly asked to put behind the deal sat just out of reach.
He had done everything right, and he was still staring at the space between under contract and funded.
That space is where deals die. Not because the buyer was wrong, and not because the lender was wrong, but because no one had shown him how to build the rest of the stack. That is the entire reason this session exists.
Who this is for
Healthcare Acquisition Buyers
Behavioral health, pharmacy, medical real estate, and clinical roll-ups. You are under a signed LOI, approved for part of the purchase, and short the rest.
Operating-Asset and Receivership Buyers
A plant, a facility, or a portfolio, including out of receivership. Buying land, machinery and stock with no seller note? This session covers how that stack funds differently.
Approved For One Number, Building Toward A Larger One
Approved for $5M, assembling a $45M platform. Where the conventional ceiling caps out, and how operators structure past it for the roll-up.
What you will walk away with
Thirty minutes of teaching, fifteen minutes of your questions, on one thing: how to fund the acquisition you have already put under contract. No theory, no pitch. You bring the deal you have already signed, and we work your actual capital stack.
The Seat Fee
$20 USD. It confirms your place, and nothing more.
That is a platform seat fee, not an AltFunds Global advisory fee. The AltFunds Global advisory fee is success-based and disclosed in writing before you incur any third-party cost. If the capital never funds, there is no AltFunds Global success fee.
Third-party costs such as due diligence and escrow are paid to third parties, not to us, and you can pay those and still not proceed to a term sheet. Nothing moves forward without your approval, and you can pause anytime.
Taimour Zaman
Founder of AltFunds Global, a global financial advisory firm working from Toronto, Canada and Zurich, Switzerland. Not a lender and not a fund. AFG structures the capital file and connects the right capital provider to the right deal, on files from $1M to $500M. Taimour runs this session personally, and works your actual capital stack rather than theory.
Questions
Operators under a signed LOI to buy a healthcare or operating business, bringing thin equity, approved for part of the capital stack but not the whole close. Segments: behavioral health, pharmacy, medical real estate, clinical roll-ups, and operating-asset or receivership purchases. Built for operators, not CFOs.
Most teach how to buy a business in general. This one is closed to anyone without a signed LOI. You bring your live deal and we work your actual capital stack, in the healthcare and receivership verticals nobody else specializes in, at institutional scale ($1M to $500M).
The gap between a signed LOI and a funded close. Most buyers are approved for the senior debt but must self-source roughly 10 to 20% beyond it. A majority of self-funded acquisition buyers must raise outside capital to close.
No. AltFunds Global is a global financial advisory firm, not a lender and not a fund. It structures the file and connects the right capital provider to the right deal, for files from $1M to $500M, from Toronto, Canada and Zurich, Switzerland.
The advisory fee is success-based and disclosed in writing before you incur any third-party cost. If the capital never funds, there is no AFG success fee. Third-party costs such as due diligence and escrow are paid to third parties, not to AFG. Where a timeline applies, it is 20 to 120 banking days.
A $20 seat fee is charged through the event platform to confirm your place. It is a platform seat fee, not an AltFunds Global advisory fee.
Bring a deal you have under LOI, and leave knowing how to fund it. If you are buying a healthcare or operating business, including assets out of receivership, and you are approved for part of the purchase and short the rest, this room was built for you.